Lukacs, B <br/><br/>
One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice.  [electronic resource] 

 -  Urology  Apr 2000 
 - 540-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/s0090-4295(99)00539-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic alpha-Antagonists--adverse effects<br/>Aged<br/>Aged, 80 and over<br/>Family Practice<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Postoperative Complications--drug therapy<br/>Prostatectomy<br/>Prostatic Hyperplasia--drug therapy<br/>Quality of Life<br/>Quinazolines--adverse effects<br/>Recurrence<br/>Sickness Impact Profile<br/>Urinary Retention--drug therapy<br/>Urodynamics--drug effects